OBJECTIVE: Cell-free fetal DNA (cffDNA) in maternal plasma results from degradation of fetal and/or placental cells. Our objective was to determine if chorionic villus sampling (CVS) causes increased release of fetal and/or maternal DNA. METHODS: Fifty-two pregnant women were recruited prior to CVS, performed for clinical indications, at 10 5/7 to 13 2/7 weeks. Maternal blood was collected before and within 15 min after CVS. cffDNA was extracted from plasma. Real-time polymerase chain reaction (PCR) amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the Y chromosome sequence DYS1 were used as measures of total and fetal DNA, respectively. All samples were analyzed in triplicate without knowledge of fetal gender. RESULTS: Sensitivity of DYS1 detection in male fetuses was 100% (n = 30); specificity in female fetuses was 100% (n = 22). While a majority of women had > 50% post-procedure increases in both fetal and total DNA, some showed post-procedure decreases. However, overall median proportional increases were not statistically significant. Gestational age (GA), placental location, and individual CVS operator did not correlate with changes in DNA levels. CONCLUSIONS: While there were no statistically significant overall changes in DNA levels after CVS, as-yet undiscovered variables may influence the extent of post-procedure release of cell-free DNA in the circulation of pregnant women. Copyright (c) 2010 John Wiley & Sons, Ltd.
OBJECTIVE: Cell-free fetal DNA (cffDNA) in maternal plasma results from degradation of fetal and/or placental cells. Our objective was to determine if chorionic villus sampling (CVS) causes increased release of fetal and/or maternal DNA. METHODS: Fifty-two pregnant women were recruited prior to CVS, performed for clinical indications, at 10 5/7 to 13 2/7 weeks. Maternal blood was collected before and within 15 min after CVS. cffDNA was extracted from plasma. Real-time polymerase chain reaction (PCR) amplification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the Y chromosome sequence DYS1 were used as measures of total and fetal DNA, respectively. All samples were analyzed in triplicate without knowledge of fetal gender. RESULTS: Sensitivity of DYS1 detection in male fetuses was 100% (n = 30); specificity in female fetuses was 100% (n = 22). While a majority of women had > 50% post-procedure increases in both fetal and total DNA, some showed post-procedure decreases. However, overall median proportional increases were not statistically significant. Gestational age (GA), placental location, and individual CVS operator did not correlate with changes in DNA levels. CONCLUSIONS: While there were no statistically significant overall changes in DNA levels after CVS, as-yet undiscovered variables may influence the extent of post-procedure release of cell-free DNA in the circulation of pregnant women. Copyright (c) 2010 John Wiley & Sons, Ltd.
Authors: Tuangsit Wataganara; Erik S Leshane; Angela Y Chen; Lisa M Sullivan; Inga Peter; Lynn Borgatta; Kirby L Johnson; Diana W Bianchi Journal: Ann N Y Acad Sci Date: 2004-06 Impact factor: 5.691
Authors: Kirby L Johnson; Kimberly A Dukes; John Vidaver; Erik S LeShane; Idania Ramirez; William D Weber; Farideh Z Bischoff; Sinuhe Hahn; Arun Sharma; Dianne X Dang; Lisa M Hire; Diana W Bianchi; Joe Leigh Simpson; Wolfgang Holzgreve; Sherman Elias; Katherine W Klinger Journal: Clin Chem Date: 2004-01-12 Impact factor: 8.327
Authors: Adam C Urato; Inga Peter; Jacob Canick; Geralyn Lambert-Messerlian; Andrea Pulkkinen; George Knight; Young-Ju Jeong; Kirby L Johnson; Diana W Bianchi Journal: Prenat Diagn Date: 2008-03 Impact factor: 3.050
Authors: Tuangsit Wataganara; Angela Y Chen; Erik S LeShane; Lisa M Sullivan; Lynn Borgatta; Diana W Bianchi; Kirby L Johnson Journal: Fertil Steril Date: 2004-03 Impact factor: 7.329
Authors: Ji Hyae Lim; Min Hyoung Kim; You Jung Han; Da Eun Lee; So Yeon Park; Jung Yeol Han; Moon Young Kim; Hyun Mee Ryu Journal: PLoS One Date: 2013-02-15 Impact factor: 3.240